| |
| |
|
| Insider
Information: |
Bcip Life Sciences Associates, Lp |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
22,715,834 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$35,383,284 |
|
|
| Total
Shares |
22,715,834 |
|
|
| Total
Value |
$35,383,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xilio Therapeutics, Inc. |
XLO |
10% Owner |
|
0 |
2021-12-10 |
2,805,413 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
|
0 |
2024-01-11 |
4,034,582 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
10% Owner |
2023-05-25 |
0 |
2023-05-25 |
5,401,926 |
Premium* |
|
|
Newamsterdam Pharma Ord Shs |
NAMS |
10% Owner |
|
0 |
2023-12-29 |
10,473,913 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLDB |
Solid Biosciences Inc |
|
– • • |
2024-01-11 |
4 |
A |
$5.53 |
$5,000,005 |
I/I |
904,160 |
4,034,582 |
0 |
- |
|
| NAMS |
Newamsterdam Pharma Ord S... |
10% Owner |
– – • |
2023-12-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,473,913 |
|
- |
|
| ANNX |
Annexon, Inc. |
10% Owner |
– – • |
2023-05-25 |
4 |
B |
$2.13 |
$639,720 |
I/I |
300,000 |
5,701,926 |
1.5 |
- |
|
| ANNX |
Annexon, Inc. |
10% Owner |
– – • |
2023-05-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,401,926 |
|
- |
|
| SLDB |
Solid Biosciences Inc |
10% Owner |
– – • |
2022-12-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,130,423 |
|
% |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-10 |
4 |
B |
$9.56 |
$241,202 |
I/I |
25,000 |
2,805,413 |
1.5 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-09 |
4 |
B |
$9.84 |
$39,485 |
I/I |
4,011 |
2,780,413 |
1.5 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-08 |
4 |
B |
$9.62 |
$129,474 |
I/I |
13,458 |
2,776,402 |
1.5 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,762,944 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
